Atezolizumab,Cabozantinib
Roche
['kcsm,(-skcsm)', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo', 'cabozantinib']
cabozantinib/atezolizumab combo misses pfs, os end points in ici-treated, advanced rcc #asco23 #asco2023 #kcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.